New AI-powered diagnostics push IDEXX Catalyst One beyond routine blood work

IDEXX is leaning on AI and integrated workflows to keep its Catalyst One analyzer at the center of small-animal practices, as more vets automate chemistry, electrolytes and endocrine testing directly in the clinic.

Edited by ad hoc news New Releases & Launches Desk. Reviewed before publication on 06/16/2026 at 1:29 PM ET. Details in the imprint.

The compact Catalyst One chemistry analyzer from IDEXX Laboratories has quietly become a workhorse in small-animal clinics, and the company is now layering more AI-driven decision support and flexible test menus on top of the platform to keep it core to in-house diagnostics. The benchtop system is designed to deliver up to 30 chemistry parameters from a single whole-blood, serum or plasma sample in minutes, with workflows tuned for busy veterinary teams.

What Catalyst One does in the exam-room lab

At its core, the Catalyst One is a fully automated clinical chemistry analyzer built for veterinary practices that want laboratory-grade biochemistry results without outsourcing every panel to a reference lab. According to the official IDEXX product documentation, the system can run chemistry, electrolyte and immunoassay tests, with many routine chemistry profiles completing in about 8 minutes from sample loading to result printout, helping practices make same-visit decisions on wellness, pre-anesthetic and sick-patient workups. The manufacturer product page details the menu and turnaround times.

The analyzer uses single-use dry-slide reagent clips and rotors, allowing clinics to customize each run by selecting only the analytes they need, from basic chemistries such as ALT, ALP and BUN to add-on tests like SDMA for early kidney assessment and CRP in canine inflammation panels. IDEXX positions this approach as a way to control per-test cost while still giving veterinarians broad diagnostic coverage, because the instrument reads each slide independently rather than forcing pre-bundled panels on every case. That modularity also reduces wastage compared with multi-test wet chemistry systems that may expire partially unused in low-volume clinics.

Integration across the IDEXX ecosystem is a second pillar of the Catalyst One strategy. The analyzer can connect to IDEXX VetLab Station middleware and the cloud-based IDEXX 4D platform so that results feed directly into practice management systems, electronic medical records and telemedicine consults, cutting down on manual data entry and transcription errors. IDEXX markets this as part of a “practice-wide” diagnostic workflow in which hematology from its ProCyte One, urinalysis from the SediVue Dx and images from the company’s imaging solutions are consolidated to support longitudinal patient tracking, clinical decision support algorithms and analytics on practice performance. For vets, that means chemistry data from Catalyst One is instantly available for trend charts, automated reminders and client-facing reports.

Beyond workflow and connectivity, IDEXX has been using software updates and menu expansion to keep the platform current. The company has added new slides for biomarkers such as symmetric dimethylarginine (SDMA), which is promoted as enabling earlier detection of kidney function changes compared with creatinine alone, and specialty tests in areas like endocrine diagnostics. In parallel, IDEXX has been rolling out AI-assisted interpretation tools on its cloud platforms that can flag patterns in chemistry results associated with common disease processes, supporting less-experienced clinicians and helping standardize care across multi-site practices and corporate veterinary chains. While the analyzer hardware remains the same, these incremental additions effectively extend the useful life of installed units and create recurring revenue via consumables and software services.

For many clinics, economics are as important as technical specifications. Catalyst One is marketed as a mid-range analyzer below IDEXX’s larger Catalyst Dx platforms, with a footprint suited for small exam-room labs and pricing structured around a combination of instrument placement and reagent usage instead of a single large capital outlay. That model is attractive to independent practices and emerging markets that want to expand in-house diagnostics without committing to a full-size lab, and it aligns with IDEXX’s broader strategy of driving recurring consumables and services revenue from a growing installed base of analyzers.

IDEXX has repeatedly highlighted its point-of-care diagnostic instruments, including Catalyst One, as a primary growth engine within its Companion Animal Group, which generates the bulk of the company’s revenue. In recent filings and investor presentations, management has emphasized double-digit growth in in-house diagnostics consumables and placements as clinics increase utilization of chemistry and other analyzers. The company’s investor relations materials describe the Catalyst line as central to that long-term strategy.

Within that context, the continued expansion of test menus, integration features and AI-supported workflows around Catalyst One is less about a single new product launch and more about defending a profitable installed base in the face of competing veterinary analyzers and reference lab offerings. Shares of IDEXX Laboratories (US45168D1046) traded on NASDAQ at around $480 in recent sessions, valuing the diagnostics specialist firmly in the large-cap growth segment of the US health-care tools and services universe. Nasdaq market data show IDEXX listed under the ticker IDXX.

IDEXX Catalyst One key facts at a glance

• Product: Catalyst One chemistry analyzer
• Manufacturer: IDEXX Laboratories Inc.
• Category: New Release / Launch - point-of-care veterinary chemistry analyzer
• Launch date: Initially introduced in the mid-2010s; continuously updated via menu and software additions
• MSRP / Price: Placement and reagent-usage-based pricing; exact instrument price varies by clinic agreement
• Availability: Sold primarily through IDEXX’s direct sales network and distributor partners for veterinary practices in North America, Europe and select international markets
• Target audience: Small-animal veterinary practices, multi-site clinics and corporate veterinary groups seeking in-house chemistry testing
• Key differentiator / USP: Fast, customizable dry-slide chemistry menu integrated with IDEXX’s broader diagnostic ecosystem and cloud-based software tools

This article was a.i.-assisted and editorially reviewed. Product information without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Trading involves risk up to and including the total loss of invested capital.